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Over 80% of diffuse intrinsic pontine gliomas (DIPGs) harbor a point mutation in histone
H3.3 where lysine 27 is substituted with methionine (H3.3K27M); however, how the
mutation affects kinetics and function of PcG proteins remains elusive. We demonstrate that
H3.3K27M prolongs the residence time and search time of Ezh2, but has no effect on its
fraction bound to chromatin. In contrast, H3.3K27M has no effect on the residence time of
Cbx7, but prolongs its search time and decreases its fraction bound to chromatin. We show
that increasing expression of Cbx7 inhibits the proliferation of DIPG cells and prolongs its
residence time. Our results highlight that the residence time of PcG proteins directly cor-
relates with their functions and the search time of PcG proteins is critical for regulating their
genomic occupancy. Together, our data provide mechanisms in which the cancer-causing
histone mutation alters the binding and search dynamics of epigenetic complexes.
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Epigenetic regulatory complexes play an essential role in theorganization of chromatin structure, thereby modulatinggene expression1. Polycomb group (PcG) proteins are well-
characterized epigenetic regulators that are assembled into two
distinct complexes, Polycomb repressive complex (PRC) 1 and
PRC22. PRC2 catalyzes trimethylation of histone H3 on lysine 27
(H3K27me3) via the catalytic subunit Ezh2 or Ezh13–7. PRC1
complexes can ubiquitinate histone H2A at lysine 119
(H2AK119Ub) through their catalytic subunit Ring1a or Ring1b.
Based on the protein subunit composition of these individual
PRC1 complexes, they are divided into “canonical” or “variant”
complexes8,9. Canonical PRC1 complexes (Cbx-PRC1; the func-
tional homolog to Drosophila PRC1) assemble with either Pcgf2
(Mel18) or Pcgf4 (Bmi1), and incorporate a chromobox (Cbx)
protein. PcG proteins play crucial roles during disease patho-
genesis. Cbx7, one of the core components of Cbx-PRC1, and
Ezh2 can be a proto-oncogene or a tumor suppressor in a
context-dependent manner10–15.
Diffuse intrinsic pontine gliomas (DIPGs) are aggressive pri-
mary brainstem tumors with a median age at diagnosis of 6–7
years and the leading cause of brain tumor-related death in
children16. Recent genomic studies revealed that up to 80% of
DIPG tumors exhibit a characteristic mutation of lysine 27 to
methionine (K27M) in genes encoding histone H3.3 (H3F3A),
and, to a lesser extent, H3.1 (HIST3H1B)17–19. H3K27M
mutation occurs in a single allele of a total of 32 copies of
histone H3 genes, and therefore only a minor fraction
(3.6–17.6%) of the total H3 protein in DIPGs is the mutant20.
Subsequent studies showed that the H3K27M mutation results in
a global reduction of H3K27me3 levels20–23. However, the
genome-wide sequencing revealed a striking retainment of
H3K27me3 and PRC2 at selected genomic loci in H3K27M-
mutant DIPGs22,23. How H3K27M reduces global H3K27me3
levels, but selectively retains H3K27me3 at a subset of genes
in vivo is not yet fully understood.
Biochemical investigations identified that H3K27M peptides
bind to the PRC2 active site with above 20-fold higher affinity
than the equivalent peptides, H3K27M-mutant peptides or
nucleosomes inhibit the PRC2 activity20,24,25, and Ezh2 is enri-
ched on H3K27M-containing mononucleosomes isolated from
cells20,22. Based upon these classical biochemical studies20,22,24,25
and the genome-wide sequencing22,23, the sequestration model24
and the inhibition model23 have been proposed to explain the
in vivo reprogramming of H3K27me3 by H3K27M. However,
recent genome-wide studies showed that H3K27M localizes to
transcriptionally active chromatin regions and at gene regulatory
elements and PRC2 is largely excluded from chromatin on sites
containing H3K27M26, and both PRC2 and H3K27me3 are lost
from weak Polycomb targets23. Another recent biochemical study
demonstrated that PRC2 exhibits similar binding affinity for
H3K27M-nucleosomes and unmodified nucleosomes27. These
results are not fully compatible with the sequestration or inhi-
bition model. Therefore, critical knowledge gaps remain in our
understanding of the mechanistic links between the H3K27M
mutant and PRC2 functionalities. Additionally, H3K27me3 is the
mark for the targeting of Cbx7-PRC1 to chromatin28. Whether
and how H3K27M affects the Cbx7-PRC1 targeting remains
unexplored.
Direct measurement of the binding and search kinetics of PcG
proteins in vivo is necessary for our understanding of the
aforementioned mechanisms. Here, we utilize live-cell single-
molecule tracking (SMT) and genetic engineering to determine
the binding and search dynamics of PRC2 and Cbx7 and eluci-
date the kinetic mechanisms that underpin how H3.3K27M
inhibits the PRC2 activity in vitro and reprograms the genomic
occupancy of H3K27me3 and PRC2 in vivo. We further show
that elevating expression of Cbx7 inhibits the proliferation of
DIPG cells and stabilizes Cbx7 on chromatin.
Results
PRC2 and Cbx7 have different chromatin-bound fractions. To
investigate the PRC2 binding dynamics at endogenous genomic
loci within living cells, we generated mouse embryonic stem
(mES) cells stably expressing HaloTag-PRC2 subunit fusions
under the control of an inducible tetracycline response element-
tight promoter. Unless otherwise indicated, we performed live-
cell SMT experiments at the basal level of HaloTag-PRC2 subunit
fusion expression without doxycycline induction. A small sub-
population of HaloTag-PRC2 subunit fusion was labeled by
bright and photostable Janelia Fluor 549 (JF549)29 and was illu-
minated using highly inclined thin illumination (HILO) mode
(Fig. 1a)30. The number of fluorescently labeled HaloTag fusions
within cells was at a range of 5–20 particles per frame (Fig. 1b).
We used H2A-HaloTag and HaloTag-NLS (NLS, nuclear
localization sequence) to validate our live-cell SMT system28.
Please note that in some cases HaloTag is abbreviated to HT. A
large population of H2A-HaloTag was stationary (Supplementary
Movie 1) while nearly all of HaloTag-NLS were highly mobile
(Supplementary Movie 2). We tracked individual molecules and
constructed the displacement histogram and the cumulative
distribution of displacements (Fig. 1c, d). To calculate kinetic
fractions and diffusion constants, we carried out kinetic modeling
of the measured displacements using Spot-On31. The displace-
ment distribution for H2A-HaloTag was fitted to generate
chromatin-bound (F1 and D1) and free diffusion (F3 and D3)
(Fig. 1d). The displacement distribution for HaloTag-NLS was
decomposed into chromatin-bound (F1 and D1), confined
diffusion (F2 and D2), and fast diffusion (F3 and D3) (Fig. 1d).
Approximately 82% of H2A-HaloTag molecules bound to
chromatin (Fig. 1e and Supplementary Table 1), which is
consistent with a previous report using fluorescence recovery
after photobleaching (FRAP)32. In contrast, only ∼8% of
HaloTag-NLS molecules bound to chromatin (Fig. 1e and
Supplementary Table 1). Among the Cbx family proteins, Cbx7
is the well-characterized effector of H3K27me3 generated by
PRC2 in mES cells28; therefore, we quantified the kinetic fractions
and diffusion constants of Cbx7 (Fig. 1c, d and Supplementary
Movie 3). We found that ∼40% of HaloTag-Cbx7 binds to
chromatin, ∼40% is in confined diffusion, and ∼20% is in free
diffusion (Fig. 1e and Supplementary Table 1).
Given that Ezh2 is the catalytic subunit of PRC2 and Eed is the
core component of PRC2, we quantitatively measured the kinetic
fractions and diffusion constants of Ezh2 and Eed in living mES
cells (Fig. 1c–e and Supplementary Movies 4-5). We found that
∼23% of HaloTag-Ezh2 binds to chromatin, ∼23% is in confined
diffusion, and ∼54% is in free diffusion (Fig. 1e and Supplemen-
tary Table 1). Likewise, ∼20% of HaloTag-Eed associates with
chromatin, ∼29% is confined diffusion, and ∼51% is in free
diffusion (Fig. 1e and Supplementary Table 1). Since the
HaloTag-PRC2 subunit fusions and their endogenous counter-
parts co-exist within cells, the fusion proteins may be at
disadvantage to compete with their endogenous counterparts
for binding sites. To this end, we measured the kinetic fractions of
HaloTag-Ezh2 and HaloTag-Eed in Ezh2─/─ and Eed─/─ mES
cells, respectively. The kinetic fractions of HaloTag-Ezh2 and
HaloTag-Eed in their corresponding knockout mES cells were
comparable to those obtained from wild-type mES cells (Fig. 1c–e
and Supplementary Table 1). These data suggest that HaloTag is
unlikely to interfere with the competition between the fusion
proteins and their corresponding endogenous counterparts. To
investigate whether the HaloTag fusion influences the enzymatic
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activity of PRC2, we quantified the H3K27me3 level in HaloTag-
Ezh2/Ezh2─/─, HaloTag-Eed/Eed─/─, and wild-type mES cells by
immunofluorescence. Our data indicated that the H3K27me3
level in HaloTag-Ezh2/Ezh2─/─ and HaloTag-Eed/Eed─/─ mES
cells is similar to that in wild-type mES cells (Fig. 1f), suggesting
that the fusion proteins biochemically recapitulate the function of
their endogenous counterparts.
PRC2 and Cbx7 have similar stability on chromatin. The
fraction of PcG bound to specific sites is determined by the ratio
of off-rate (the inverse of residence time) and target search time
(Methods). The stability of PcG proteins on chromatin is deter-
mined by their residence time. To measure the residence time of
Ezh2 and Eed on chromatin, we performed live-cell SMT at an
integration time, τint, of 30 ms interspersed with a dark time, τd,
of 170 ms as described previously (Fig. 2a)28. We considered
molecules whose diffusion constant is less than 0.032 (µm2 per s)
as the chromatin-bound ones. This is a conservative considera-
tion since we intend to avoid counting molecules of confined
motion whose diffusion constant is at a range of 0.32–0.77 (µm2
per s) (Supplementary Table 1). We counted the lifetime of the
fluorescence spots as the dwell time of individual chromatin-
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Fig. 2 PRC2 and Cbx7 possess a similar residence time, but exhibit distinct search dynamics. a Example images showing single HaloTag-Ezh2 molecules
binding to and unbinding from chromatin. The red arrowhead indicates the HaloTag-Ezh2 molecules bound to chromatin and the green arrowhead
represents the HaloTag-Ezh2 molecules unbound from chromatin. Scale bar is 5.0 µm. b Survival probability distribution of the dwell times for
HaloTag-Ezh2 in wild-type (N= 112 cells, n= 4854 trajectories) and Ezh2−/− (N= 77 cells, n= 2365 trajectories) mES cells, for HaloTag-Eed in wild-type
(N= 47 cells, n= 3533 trajectories) and Eed−/− (N= 56 cells, n= 1222 trajectories) mES cells, and for HaloTag-Cbx7 (N= 27 cells, n= 1924 trajectories)
and HaloTag-NLS (N= 61 cells, n= 2973 trajectories) in wild-type mES cells. The distributions were fitted with a two-component exponential decay model.
Fitted parameters are shown in Supplementary Table 2. c Residence time of the short-lived (τtb) and long-lived (τsb) population for HaloTag-Ezh2 in wild-
type and Ezh2−/− mES cells, for HaloTag-Eed in wild-type and Eed−/− mES cells, and for HaloTag-Cbx7 and HaloTag-NLS in wild-type mES cells. Results
are means ± SD. d Fraction of the short-lived (F1tb) and long-lived (F1sb) population for HaloTag-Ezh2 in wild-type and Ezh2−/− mES cells, for HaloTag-Eed
in wild-type and Eed−/− mES cells, and for HaloTag-Cbx7 in wild-type mES cells. Results are means ± SD. e Schematic representation of the nuclear search
mechanisms of PcG proteins. The target search time (τsearch, solid curved arrowhead) denotes PcG proteins that find a specific site. We assume that the
nucleosomal characteristics of the long-lived and short-lived PcG-binding sites are different, as depicted by different size and color. Magenta cylinder
represents nucleosomes to which PcG proteins transiently bind, while red cylinder indicates nucleosomes to which PcG proteins specifically bind. f Search
time (τsearch) of the long-lived population for HaloTag-Ezh2 in wild-type and Ezh2−/−mES cells, for HaloTag-Eed in wild-type and Eed−/−mES cells, and for
HaloTag-Cbx7 in wild-type mES cells. Results are means ± SD from three biological replicates
Fig. 1 PRC2 and Cbx7 exhibit distinct capacities for binding to chromatin. a Schematic illustrating HILO (highly inclined and laminated optical sheet). b
Example image showing single HaloTag-Ezh2 molecules labeled with JF549 dye during a 30ms exposure time. The nucleus was marked by oval white dash
circle. The individual white points represent single HaloTag-Ezh2 molecules. Scale bar, 2.0 µm. c Displacement histograms for H2A-HaloTag (N= 52 cells,
n= 6172 displacements), HaloTag-NLS (N= 66 cells, n= 6587 displacements), and HaloTag-Cbx7 (N= 40 cells, n= 7725 displacements) in wild-type
mES cells, for HaloTag-Ezh2 in wild-type (N= 30 cells, n= 5532 displacements) and Ezh2−/− (N= 50 cells, n= 14,427 displacements) mES cells, and for
HaloTag-Eed in wild-type (N= 36 cells, n= 5444 displacements) and Eed−/− (N= 77 cells, n= 8845 displacements) mES cells. The short dash red curve
indicates the overall fit. NLS, nuclear localization sequence. HT, HaloTag. d Cumulative distribution of displacements for H2A-HaloTag, HaloTag-NLS, and
HaloTag-Cbx7 in wild-type mES cells, for HaloTag-Ezh2 in wild-type and Ezh2−/− mES cells, and for HaloTag-Eed in wild-type and Eed−/− mES cells. The
cumulative distributions were fitted with two or three components. Fitted parameters are shown in Supplementary Table 1. Unless otherwise indicated, the
reported kinetic fractions and diffusion constants were obtained from the cumulative distributions. Solid curve represents raw data. Short dash curve is
fitted data. e Fraction of the chromatin-bound population (F1) obtained from d. Results are means ± SD from three biological replicates. f Immunostaining of
H3K27me3 in wild-type, Ezh2─/─, Eed─/─, HaloTag-Ezh2/Ezh2─/─, and HaloTag-Eed/Eed─/─ mES cells by using antibody directed against H3K27me3
(green). DNA was stained with hoechst (red). Overlay images are shown. The residual H3K27me3 level was detectable in Ezh2─/─ mES cells because of
the presence of Ezh1. Scale bar, 5.0 µm
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bound molecules. We fitted the survival curves by a double or
single exponential decay function to generate the short-lived (f1tb
and τtb) and long-lived (f1sb and τsb) population (Fig. 2b and
Methods). After correcting for photobleaching, we estimated the
τtb of HaloTag-Ezh2 and HaloTag-Eed as ∼0.9 s and their τsb as
∼10 s in wild-type mES cells (Fig. 2c and Supplementary Table 2).
The residence times of HaloTag-Ezh2 and HaloTag-Eed in their
corresponding knockout mES cells were similar to that in wild-
type mES cells (Fig. 2c and Supplementary Table 2). The resi-
dence time of PRC2 is similar to that of some transcription fac-
tors reported so far33–39. Since the control HaloTag-NLS
exhibited a negligible long-lived population (Fig. 2c and Supple-
mentary Table 2), we refer to the long-lived molecules as ones
that bind stably to specific sites and the short-lived molecules as
ones that bind transiently to non-specific sites. It should be noted
that we assume that the specific sites have similar affinity for PcG
proteins.
Since the level of Cbx7 bound to chromatin is two-fold larger
than that of Ezh2 and Eed, we compared their residence times.
Interestingly, our results indicated that the residence times of
both short-lived and long-lived HaloTag-Cbx7 are nearly
identical to that of Ezh2 and Eed (Fig. 2c and Supplementary
Table 2), suggesting that PRC2 and Cbx7 exhibit similar stability
on chromatin.
The bound level (F1) of PcG proteins is the sum of the short-
lived (F1tb) and long-lived (F1sb) fractions (Methods). We
estimated that within wild-type and Ezh2−/− mES cells, ∼18%
(F1tb) of HaloTag-Ezh2 molecules bind transiently to chromatin
and ∼4.4% (F1sb) bind stably to chromatin (Fig. 2d and
Supplementary Table 2). Similar analysis of HaloTag-Eed in
wild-type and Eed−/− mES cells indicated that ∼17% (F1tb) binds
transiently to chromatin and ∼4.2% (F1sb) binds stably to
chromatin (Fig. 2d and Supplementary Table 2), indicating that
Ezh2 and Eed have similar short-lived and long-lived fractions.
Live-cell SMT analysis of HaloTag-Cbx7 indicated that ∼27%
(F1tb) of molecules bind transiently to chromatin and ∼13% (F1sb)
bind stably to chromatin.
Taken together, our analyses show that PRC2 and Cbx7 exhibit
similar stability (residence time) on chromatin. Thus, their target
search processes determine their fractions bound to chromatin.
PRC2 and Cbx7 exhibit distinct nuclear search dynamics. To
characterize the nuclear search dynamics, we analyzed the target
search time (τsearch) of PRC2 and Cbx7 (Fig. 2e and Methods).
Within mES cells, after dissociating from a specific site, HaloTag-
Ezh2 required ∼210 s to find another specific site (Fig. 2f and
Supplementary Table 2). HaloTag-Eed and HaloTag-Ezh2 had
similar times when finding specific sites (Fig. 2f and Supple-
mentary Table 2). The search times of HaloTag-Ezh2 and
HaloTag-Eed in their corresponding knockout mES cells were
similar to that in wild-type mES cells (Fig. 2f and Supplementary
Table 2). In contrast, HaloTag-Cbx7 took ∼64 s to find a specific
site (Fig. 2f and Supplementary Table 2). The short search time of
HaloTag-Cbx7 is due to the fact that HaloTag-Cbx7 takes fewer
trials to find a specific site than PRC2, and spends less time
between two binding events (τ3D) (Supplementary Table 2 and
Methods). Together, our data indicate that Cbx7 and PRC2 have
similar stability on chromatin, but Cbx7 is more efficient at
finding specific sites than PRC2. Thus, the long-lived fraction of
Cbx7 is larger than that of PRC2.
Effects of Eed and Suz12 on the dynamics of Ezh2. The minimal
catalytically active PRC2 is comprised of Ezh2, Eed, and Suz1240.
Eed recognizes H3K27me3, which is critical for the propagation
of H3K27me341,42. We determined whether Eed is required for
the stability and search process of Ezh2. To this end, we inte-
grated HaloTag-Ezh2 into the genome of Eed−/− mES cells.
Interestingly, the depletion of Eed had no effect on the
chromatin-bound fraction (F1) and the long-lived population
(F1sb) (Fig. 3c, e; Supplementary Fig. 1, and Supplementary
Table 3 and 4), but the residence time of long-lived HaloTag-
Ezh2 molecules was reduced by ∼30% (from ∼10 to ∼7.0 s)
(Fig. 3d, f, and Supplementary Table 4), suggesting Eed is


























































































Fig. 3 Eed and Suz12 are required for the stability of Ezh2 on chromatin, but
have different effects on its target search process. a Schematic
representation of Ezh2. The N-terminus of Ezh2 interacts with Eed. The
SANT2 domain (red rectangle) interacts with Suz12. The C-terminus of
Ezh2 is the catalytic lobe, including cysteine-rich domain (CXC, yellow
rectangle) and SET domain (green rectangle) that is the catalytic domain of
Ezh2. b Cumulative distribution of displacements for HaloTag-Ezh2
replicated from Fig. 1, for HaloTag-Ezh2 (N= 64 cells, n= 11437
displacements) in Eed−/− mES cells, and for HaloTag-Ezh2ΔSANT2
(N= 71 cells, n= 5981 displacements) in wild-type mES cells. The
cumulative distributions were fitted with three populations. Fitted
parameters are shown in Supplementary Table 3. c Fraction of the
chromatin-bound population (F1) obtained from Fig. 3b. Results are means
± SD. d Survival probability distribution of the dwell times for HaloTag-Ezh2
replicated from Fig. 2, for HaloTag-Ezh2 (N= 93 cells,
n= 2339 trajectories) in Eed−/− mES cells, and for HaloTag-Ezh2ΔSANT2
(N= 85 cells, n= 2728 trajectories) in wild-type mES cells. The
distributions were fitted with a two-component exponential decay model.
Fitted parameters are shown in Supplementary Table 4. e–g Fraction (e),
residence time (f), and search time (g) of the long-lived population (F1sb)
for HaloTag-Ezh2 replicated from Fig. 2, for HaloTag-Ezh2 in Eed−/− mES
cells, and for HaloTag-Ezh2ΔSANT2 in wild-type mES cells. Results are
means ± SD from three biological replicates
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of HaloTag-Ezh2 in Eed−/− mES cells was ∼70% of that in wild-
type mES cells (Fig. 3g and Supplementary Table 4). Thus, our
analyses demonstrate that the depletion of Eed destabilizes Ezh2
on chromatin and shortens the search process of Ezh2, thereby
having no effect on its long-lived fraction.
Suz12 is essential for the PRC2 activity40,43. To understand how
Suz12 contributes to the binding kinetics and search process of
Ezh2, we deleted the SANT2 domain of Ezh2 (Ezh2ΔSANT2) since
the SANT2 domain interacts with Suz1224 (Fig. 3a). The bound
fraction (F1) of HaloTag-Ezh2ΔSANT2 was similar to that of
HaloTag-Ezh2 (Fig. 3b, c; Supplementary Fig. 1, and Supplemen-
tary Table 3); however, the long-lived fraction was reduced by over
50% (Fig. 3e and Supplementary Table 4). The deletion of the
SANT2 domain also resulted in a ∼50% reduction in the residence
time of long-lived molecules (Fig. 3d, f; Supplementary Table 4).
The search time of HaloTag-Ezh2ΔSANT2 increased (Fig. 3g and
Supplementary Table 4). Thus, our results indicate that the
disruption of interactions between Ezh2 and Suz12 destabilizes
Ezh2 on chromatin and prolongs its search process, thereby
reducing its long-lived fraction.
Effects of H3.3K27M on the bound level of Cbx7 and Ezh2.
Since H3.3K27 is the substrate of Ezh2 and the Ezh2-catalyzed
product H3K27me3 is critical for the targeting of Cbx7 to chro-
matin3–6,28, we investigated the effects of the H3.3K27M muta-
tion on the kinetic fractions of Ezh2 and Cbx7. To this end, we
established HEK293T cell lines that stably express pairs of
HaloTag-Ezh2/H3.3-FLAG, HaloTag-Ezh2/H3.3K27M-FLAG,
HaloTag-Cbx7/H3.3-FLAG, or HaloTag-Cbx7/H3.3K27M-FLAG.
We showed that the expression of H3.3K27M results in a ∼7.0-
fold reduction of the H3K27me3 level compared to the expression
of H3.3 (Fig. 4a and Supplementary Fig. 2). This is consistent with
previous reports20,22. Live-cell SMT analysis demonstrated that
the fraction (F1) of HaloTag-Ezh2 bound to chromatin in H3.3-
expressing cells is the same as that in H3.3K27M-expressing cells
(Fig. 4b, c; Supplementary Fig. 3, and Supplementary Table 5),
suggesting that H3.3K27M does not influence the chromatin-
bound level of Ezh2. The diffusion coefficients of Ezh2 in H3.3-
expressing and H3.3K27M-expressing cells were similar, con-
sistent with previous results measured from FRAP and fluores-
cence correlation microscopy (FCS)44. In contrast, the expression
of H3.3K27M resulted in a ∼30% reduction in the level of
HaloTag-Cbx7 bound to chromatin in comparison with the
expression of H3.3 (Fig. 4b, c; Supplementary Fig. 3, and Sup-
plementary Table 5), indicating that H3.3K27M alters the bound
level of Cbx7 with chromatin. These results are consistent with
the targeting of Cbx7 to chromatin depending on H3K27me328.
Since motion blur of molecules can potentially lead to an over-
estimation of chromatin-bound fraction, we performed SMT at a
series of exposure times (5, 10, and 20 ms) with a consistent laser
power (Supplementary Fig. 4). Motion blur led to a slight over-
estimation of PcG proteins bound to chromatin, but did not affect
the conclusion. Thus, H3.3K27M has negligible effects on the
level of Ezh2 bound to chromatin, but affects the level of Cbx7
bound to chromatin instead (Supplementary Fig. 4 and Supple-
mentary Table 5).
To test the effects of the H3.3K27M mutation on the bound
fractions of Ezh2 and Cbx7 in more physiologically relevant
conditions, we stably expressed HaloTag-Ezh2 and HaloTag-Cbx7
in a DIPG patient-derived tumor cell line (SF8628) containing the
heterozygous H3.3K27M mutation and in a control brain tumor
cell line (9427)22. Our analysis indicated that the H3K27me3 level
in SF8628 is reduced by ∼2.0-fold in comparison with 9427 cells
(Fig. 4d; Supplementary Fig. 2). Similar live-cell SMT analysis
demonstrated that the bound fraction of HaloTag-Ezh2 in SF8628
cells is almost identical to that in 9427 cells; however, the bound
level of HaloTag-Cbx7 in SF8628 cells is reduced by ∼30%
compared to 9427 cells (Fig. 4e, f; Supplementary Fig. 3, and
Supplementary Table 5). Analysis under the conditions of
different exposure times reached the same conclusion. Together,
H3.3K27M has no effect on the level of Ezh2 bound to chromatin;
however, there is a reduction in the bound level of Cbx7
(Supplementary Fig. 5 and Supplementary Table 5).
Effects of H3.3K27M on the binding of Cbx7 and Ezh2. We
determined how H3.3K27M influences the stability of Ezh2 and
Cbx7 on chromatin. We found that the residence time
(τsb= 15.3 s) of long-lived HaloTag-Ezh2 molecules is ∼1.5-fold
longer in HEK293T cells expressing H3.3K27M than that
(τsb= 10.2 s) in HEK293T cells expressing H3.3K27 (Fig. 5a, c,
and Supplementary Table 6). Similarly, the residence time
(τsb= 11.8 s) of long-lived Ezh2 molecules in patient-derived
SF8628 cells was ∼1.4-fold longer than that in control 9427 cells
(τsb= 8.7 s) (Fig. 5b, c and Supplementary Table 6). The fraction
of long-lived HaloTag-Ezh2 in cells with H3.3K27M mutant was
similar to that in cells with wild-type H3.3 (Fig. 5d and Supple-
mentary Table 6). These data suggest that H3.3K27M stabilizes
Ezh2 on chromatin, but has no effect on its long-lived fraction.
In contrast to Ezh2, we found that the residence time of long-
lived HaloTag-Cbx7 molecules in cells carrying H3.3K27M is
similar to that in cells carrying H3.3 (Fig. 5a–c, and Supplemen-
tary Table 6). However, the fraction of long-lived HaloTag-Cbx7
in cells expressing H3.3 was ∼1.5-fold larger than that in cells
expressing H3.3K27M (Fig. 5d and Supplementary Table 6). These
data indicate that H3.3K27M has no effect on the stability of Cbx7
on chromatin, but reduces its fraction bound to chromatin.
H3.3K27M prolongs the search processes of Ezh2 and Cbx7.
Next, we determined how H3.3K27M affects the search processes
of Ezh2 and Cbx7. We found that HaloTag-Ezh2 in cells with
H3.3K27M takes ∼1.4-fold longer time to find specific sites than
in cells with H3.3 (Fig. 5e and Supplementary Table 6). Our
analyses showed that HaloTag-Cbx7 in cells carrying H3.3K27M
takes ∼1.5-fold longer time to find specific sites than in cells
carrying H3.3 (Fig. 5e and Supplementary Table 6). These data
indicate that H3.3K27M prolongs the search processes of Ezh2
and Cbx7.
In summary, H3.3K27M stabilizes Ezh2 on chromatin and
prolongs its search process, thereby having no effect on its level
bound to chromatin (Fig. 5f). H3.3K27M has no effect on the
stability of Cbx7 on chromatin, but lengthens its search time,
thereby reducing its fraction on chromatin (Fig. 5f).
H3.3K27M stabilizes PRC2 on nucleosomes. Since PRC2
functions as a multiprotein complex, it is possible that other
subunits rather than Ezh2 bind H3.3K27M. Since PRC2 recog-
nizes H3K27M via its catalytic lobe in vitro24,45, we tested whe-
ther H3.3K27M stabilizes the catalytic lobe on chromatin in vivo.
We fused the catalytic lobe with HaloTag to generate HaloTag-
Ezh2Catalytic (Fig. 3a). We established HEK293T cell lines that
stably express HaloTag-Ezh2Catalytic/H3.3-FLAG or HaloTag-
Ezh2Catalytic/H3.3K27M-FLAG. Similar to HaloTag-Ezh2, the
fraction of HaloTag-Ezh2Catalytic bound to chromatin in
HEK293T cells with H3.3K27M-FLAG was similar to that in
HEK293T cells with H3.3-FLAG (Fig. 6a, b, d; Supplementary
Fig. 6, and Supplementary Tables 7 and 8). The residence time
(∼7.3 s) and search time (∼277 s) of HaloTag-Ezh2Catalytic in
H3.3K27M-FLAG-expressing cells were both ∼1.6-fold of that in
H3.3-FLAG-expressing cells (Fig. 6c, e, f, and Supplementary
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Table 8). These data support that H3.3K27M stabilizes PRC2 on
chromatin via its interactions with Ezh2 in vivo.
Since cells have nucleosomes with distinct properties, it is
possible that other nucleosomes rather than H3.3K27M-nucleo-
some influence the PRC2 binding. To this end, we carried out
in vitro single-molecule binding assays (Fig. 6g and Supplemen-
tary Fig. 7). We reconstituted mononucleosomes labeled with
biotin and Alexa Fluor 488 at each end of the nucleosomal DNA.
The labeled nucleosomes were tethered to a quartz coverslip of a
flow cell that had been passivated and functionalized with
NeutrAvidin. We integrated FLAG-HaloTag-Ezh2 into the
genome of Ezh2−/− mES cells. JF646-labeled Ezh2-PRC2 was
enriched by anti-FLAG antibody and then the eluent was loaded
into the flow cell. We recorded the positions of individual
nucleosomes and followed the duration of JF646-labeled Ezh2-
PRC2 staying on nucleosomes. The dwell time of individual JF646-
labeled Ezh2-PRC2 molecules were directly measured as the
lifetime of the fluorescence spots. The cumulative frequency
distribution of dwell times was fitted with a one-component
exponential decay function (Fig. 6h). We found that JF646-labeled
Ezh2-PRC2 binds to H3.3-nuclesome with the residence time
∼257 s and to H3.3K27M-nulceosome with the residence time
∼404 s (Fig. 6i). These data indicate that H3.3K27M-nucleosomes
have better affinity for Ezh2 than H3.3-nucleosomes, which is
















































































































































HEK293T cells Patient-derived cells
HEK293T cells Patient-derived cells
Fig. 4 The DIPG H3.3K27M mutation reduces the Cbx7 level bound to chromatin, but has no effect on Ezh2. a Co-immunostaining of FLAG (yellow) and
H3K27me3 (green) in HEK293T cells expressing HaloTag-Ezh2/H3.3-FLAG, HaloTag-Ezh2/H3.3K27M-FLAG, HaloTag-Cbx7/H3.3-FLAG, or HaloTag-Cbx7/
H3.3K27M-FLAG. Quantification analysis showed that the H3K27me3 level in HEK293T cells expressing H3.3K27M-FLAG is ∼7.0-fold lower compared to
that expressing H3.3-FLAG (Supplementary Fig. 2). Scale bar, 5.0 µm. b Cumulative distribution of displacements for HaloTag-Ezh2 in HEK293T cells
expressing H3.3-FLAG (N= 54 cells, n= 9034 displacements) or H3.3K27M-FLAG (N= 127 cells, n= 22,273 displacements), and for HaloTag-Cbx7 in
HEK293T cells expressing H3.3-FLAG (N= 78 cells, n= 14,101 displacements) or H3.3K27M-FLAG (N= 89 cells, n= 15,755 displacements). The
distributions were decomposed into three populations. Fitted parameters are shown in Supplementary Table 5. c Fraction of the chromatin-bound
population (F1) for HaloTag-Ezh2 or HaloTag-Cbx7 in HEK293T cells expressing H3.3-FLAG or H3.3K27M-FLAG. The data were obtained from Fig. 4b.
Results are means ± SD. d Immunostaining of H3K27me3 in patient-derived SF8628 and control brain tumor 9427 cells by using antibody directed against
H3K27me3 (green). DNA was stained with hoechst (red). Overlay images are shown. The H3K27me3 level in 9427 cells was ∼2.0-fold higher than that in
SF8628 cells (Supplementary Fig. 2). Scale bar, 5.0 µm. e Cumulative distribution of displacements for HaloTag-Ezh2 in 9427 (N= 73 cells, n= 6806
displacements) and SF8628 (N= 43 cells, n= 6900 displacements) cells, and for HaloTag-Cbx7 in 9427 (N= 37 cells, n= 5280 displacements) and
SF8628 (N= 32 cells, n= 8181 displacements) cells. The histograms were fitted with three components. Fitted data are shown in Supplementary Table 5. f
Fraction of the chromatin-bound population (F1) for HaloTag-Ezh2 in 9427 and SF8628 cells and for HaloTag-Cbx7 in 9427 and SF8628 cells. The data
were obtained from e. Results are means ± SD from three biological replicates
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Increasing Cbx7 inhibits the proliferation of DIPG cells. It is
well known that the activities of many nuclear factors are regu-
lated by modulating their concentration in the nucleus. To this
end, we varied the expression of HaloTag-Cbx7 in 9427 and
SF8628 cells by changing doxycycline concentrations (Fig. 7a).
Immunofluorescence indicated that the protein level of Cbx7
increases with increasing doxycycline concentration (Fig. 7b).
SF8628 cells showed reduced proliferation in response to elevat-
ing HaloTag-Cbx7 concentration (Fig. 7c, d). In contrast, the
proliferation of control 9427 cells was not affected by increasing
HaloTag-Cbx7 concentration (Fig. 7c, d). Doxycycline had no
effect on the proliferation of SF8628 and 9427 cells (Fig. 7c, d).
These results demonstrate that human DIPG cells grow slowly in
response to increasing Cbx7 expression.
Elevating Cbx7 increases the stability of Cbx7 on chromatin.
The classical kinetic model shows that for a given system, the
residence time and search time are set. In living cells, elevating
nuclear factor concentrations could potentially alter the char-
acteristics of both chromatin and nuclear factors, thereby chan-
ging their stability on chromatin and search process. To
understand how elevating Cbx7 concentrations inhibits the pro-
liferation of DIPG cells, we investigated the binding and search
kinetics of Cbx7 by increasing its concentration in SF8628 cells.
Our analysis found that the total number FN1
 
of Cbx7 molecules
on chromatin increases upon increasing Cbx7 concentrations
(Fig. 8a, b; Supplementary Fig. 8, and Supplementary Table 9).
However, the number FN1sb
 
of long-lived Cbx7 molecules at
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Fig. 5 The DIPG H3.3K27M mutation prolongs the search processes of Ezh2 and Cbx7, but has different effects on their stability on chromatin. a Survival
probability distribution of the dwell times for HaloTag-Ezh2 in HEK293T cells expressing H3.3-FLAG (N= 211 cells, n= 3825 trajectories) or H3.3K27M-
FLAG (N= 160 cells, n= 3137 trajectories), and for HaloTag-Cbx7 in HEK293T cells expressing H3.3-FLAG (N= 89 cells, n= 8024 trajectories) or
H3.3K27M-FLAG (N= 45 cells, n= 6866 trajectories). The distributions were fitted with a two-component exponential decay model. Fitted data are shown
in Supplementary Table 6. b Survival probability distribution of the dwell times for HaloTag-Ezh2 in 9427 (N= 90 cells, n= 6078 trajectories) and SF8628
(N= 54 cells, n= 4485 trajectories) cells, and for HaloTag-Cbx7 in 9427 (N= 110 cells, n= 4641 trajectories) and SF8628 (N= 67 cells, n= 5376
trajectories) cells. The distributions were fitted with a two-component exponential decay model. Fitted parameters are shown in Supplementary Table 6.
c–e Residence time (c), fraction (d), and search time (e) of the long-lived population (F1sb) for HaloTag-Ezh2 and HaloTag-Cbx7. Results are means ± SD
from three biological replicates. f A proposed model for the effects of H3.3K27M on the binding and search mechanisms of PcG proteins. The H3.3K27M
mutation prolongs the residence time and search time of Ezh2, but has no effect on the bound level of Ezh2 (right, top panel). Given that the target search
time of Ezh2 is ∼20-fold longer than its residence time, we propose that the reduced sampling frequency of Ezh2 for the target sites by prolonging its target
search time reprograms the genomic distributions of H3K27me3 and PRC2 (right, top panel). The H3.3K27M mutation has no effect on the residence time
of Cbx7 on chromatin; however, increases the target search time of Cbx7, indicating that the prolonged search time by H3K27M reduces the bound level of
Cbx7 (right, bottom panel). The thicker arrowhead represents a longer search time and the bigger font depicts a prolonged residence time
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Table 10). Increasing Cbx7 concentrations increases the residence
time of long-lived Cbx7 molecules (Fig. 8c, e, and Supplementary
Table 10). The search time of Cbx7 also increased when its
concentrations were elevated (Fig. 8f and Supplementary
Table 10), which is primarily due to the fact that Cbx7 takes more
trials of non-specific chromatin collisions to reach a specific site
and increase its τ3D (Supplementary Table 10). Taken together,
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Fig. 6 The interactions between H3.3K27M and Ezh2 stabilize Ezh2 on chromatin. a Cumulative distribution of displacements for HaloTag-Ezh2Catalytic in
HEK293T cells expressing H3.3-FLAG (N= 42 cells, n= 2365 displacements) or H3.3K27M-FLAG (N= 36 cells, n= 4120 displacements). The cumulative
distributions were fitted with three populations. Ezh2Catalytic contains only the catalytic lobe (Fig. 3a). Fitted parameters are shown in Supplementary
Table 7. b Fraction of the chromatin-bound population (F1) obtained from a. Results are means ± SD. c Survival probability distribution of the dwell times for
HaloTag-Ezh2Catalytic in HEK293T cells expressing H3.3-FLAG (N= 56 cells, n= 1412 displacements) or H3.3K27M-FLAG (N= 46 cells, n= 1042
displacements). The distributions were fitted with a two-component exponential decay model. Fitted parameters are shown in Supplementary Table 8.
d–f Fraction (d), residence time (e), and search time (f) of the long-lived population (F1sb) for HaloTag-Ezh2Catalytic in HEK293T cells expressing H3.3-FLAG
or H3.3K27M-FLAG. Results are means ± SD. g In vitro single-molecule binding assay. FLAG-HaloTag-Ezh2 (F-HT-Ezh2) was expressed stably in Ezh2─/─
mES cells and labeled by JF646 dyes. FLAG-HaloTag-Ezh2-PRC2 was one-step enriched by FLAG antibody and loaded into the flow cells. Nucleosome
labeled with Alexa Fluor®488 was tethered to the surface of a coverslip that had been passivated and functionalized with NeutrAvidin. The position of
individual nucleosomes was recorded (green image). We followed the duration of FLAG-HaloTag-Ezh2-PRC2 on nucleosome (magenta image). The
colocalization of nucleosome and FLAG-HaloTag-Ezh2 indicates a binding event (overlay image). Arrowheads indicate binding events. Scale bar, 5.0 µm. h
Survival probability distribution of the dwell times for FLAG-HaloTag-Ezh2-PRC2 on H3.3-nucleosome (n= 99 trajectories) and on H3.3K27M-nucleosome
(n= 115 trajectories). The distributions were fitted with a one-component exponential decay model. i Residence time of FLAG-HaloTag-Ezh2-PRC2 on
H3.3-nucleosome and on H3.3K27M-nucleosome. Results are means ± SD from three biological replicates
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of short-lived Cbx7 molecules on the non-specific sites and sta-
bilizes Cbx7 on the specific sites; however, has no effect on the
number of long-lived Cbx7 molecules on the specific sites.
Discussion
We have determined the binding and target search kinetics of
PRC2 and Cbx7 within living mES cells and elucidated how
H3.3K27M alters their binding and target search mechanisms. In
the following, we discuss how the prolonged residence time
contributes to the inhibition of trimethylation of H3K27 by PRC2
in vitro and how the lengthened target search time regulates the
reprogramming of H3K27me3 in vivo. We also discuss how
increasing Cbx7 levels inhibits the proliferation of DIPG cells and
influences its binding and search mechanisms.
Our live-cell SMT experiments reveal that both PRC2 and
Cbx7 scan the nuclear environment by a combination of free
diffusion and transient and stable interactions with chromatin,
similar to previous reports for transcription factors36,38,46. PRC2
and Cbx7 have identical residence times (∼10 s), similar to
transcription factors33–38, but employ different target search
mechanisms. First, PRC2 needs ∼200 s to find a specific site,
while Cbx7 takes ∼60 s. Second, PRC2 spends ∼40 s in free dif-
fusion, but Cbx7 spends ∼20 s. Third, the long-lived fraction of
Cbx7 is ∼2.5-fold larger than PRC2. These data suggest that Cbx7
is more efficient in searching for its targets compared to PRC2.
Our analyses highlight that the target search time of PRC2 and
Cbx7 determines the difference in their genomic occupancy
levels.
H3K27M results in a global reduction in the H3K27me3 level,
but selectively retains a subset of loci with H3K27me3 and
PRC222,23. Our analysis indicates that H3.3K27M increases the
τsb of Ezh2 from ∼10 to ∼15 s and the τsearch of Ezh2 from ∼200
to ∼280 s. How does this explain the altered genomic occupancy
of H3K27me3 and PRC2 by H3K27M? The interval (s) of sam-
pling of specific sites by PRC2 can be described as Eq. 138.
τsb þ τsearchð Þ ´The number of specific sites
The number of PRC2 molecules in the nucleus
ð1Þ
Our single-molecule data provide evidence that H3.3K27M
prolongs not only the residence time of PRC2, but also its search
time. The search time of Ezh2 is ∼20-fold longer than its resi-
dence time. A previous report showed that the PRC2 level in
H3.3K27M-expressing cells is the same as that in H3.3-expressing
cells22. If we assume that the number of specific sites in H3.3- and
H3.3K27M-expressing cells remains unchanged, the search time
of PRC2 rather than its residence time contributes greatly to its
sampling frequency. Therefore, the lengthened search time
increases the interval of sampling of specific PcG-targeted sites.
We hypothesize that the reduced sampling frequency has differ-
ential effects on Polycomb targets: less effects on strong Polycomb
targets (more binding sites), but greater effects on weaker Poly-
comb targets (less binding sites). This model agrees with a recent
study that demonstrated strong Polycomb targets have clusters or
long CpG islands (more binding sites) and high PRC2/
H3K27me3 enrichment, while weak Polycomb target sites have
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Fig. 7 Increasing Cbx7 levels inhibits the proliferation of patient-derived DIPG cells. a Immunostaining of Cbx7 in 9427 and SF8628 cells carrying
transgenic Cbx7 under the control of TRE-tight promoter. The expression of Cbx7 was induced by a variety of doxycycline concentrations. Scale bar, 2.0 µm.
b Quantification of fluorescence intensity of Cbx7 from a. c Representative images of proliferation response of 9427 and SF8628 cells to increasing levels
of Cbx7. Images of cells treated with 0.1 and 0.5 µg per ml of Dox are not shown. Scale bar, 1000 µm. d Quantification of proliferation response of 9427 and
SF8628 cells to increasing levels of Cbx7. Values shown are the average from triplicate samples for each incubation condition
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H3K27me3 enrichment23. Weak Polycomb targets tend to lose
H3K27me3 and PRC2 while strong Polycomb targets are more
likely to retain H3K27me3 and PRC223. Thus, our live-cell single-
molecule results provide insights into the mechanism that
underpins how the reduced sampling frequency of PRC2 reduces
the global H3K27me3 level, but retains H3K27me3 at some loci.
A recent genome-wide study showed that H3K27M localizes to
transcriptionally active chromatin regions and gene regulatory
elements, and PRC2 is largely excluded from chromatin on sites
containing H3K27M26. However, another recent locus-specific
ChIP-qPCR study indicated that H3K27M is not excluded from
chromatin regions containing PRC223. The discrepancy could be
attributed to the approaches used. Our analysis indicates that
∼5% of Ezh2 molecules bind stably to chromatin in both H3.3-
and H3.3K27M-expressing cells and the residence time of these
molecules is ∼1.5-fold longer in H3.3K27M-expressing cells than
H3.3-expressing cells. PRC2 and H3K27me3 are present at
thousands of loci in DIPG cells23,26; therefore, some of the ∼5%
of Ezh2 molecules are responsible for the trimethylation of these
loci in DIPG cells and others are sequestered at H3K27M-
containing sites. The sequestered Ezh2 contributes less to the
reprogramming of H3K27me3 in vivo, while the reduced sam-
pling frequency results in the loss/retainment of H3K27me3.
Previous studies have shown that H3K27me3 is greatly reduced
in H3.3K27M-expressing cells20–22 and is the recruiting factor for
Cbx7-PRC128. Our single-molecule studies show that H3.3K27M
reduces the level of Cbx7 on chromatin and prolongs its search
time, but has no effect on its residence time. The increase of
search time of Cbx7 is due to the fact that the number of
H3K27me3 is decreased. Thus, our analyses point out that the
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Fig. 8 Elevating Cbx7 levels increases its stability on chromatin. a Cumulative distribution of displacements for HaloTag-Cbx7 in SF8628 cells
administrated with 0.1 µg per ml doxycycline replicated from Fig. 4, 1.0 µg per ml (N= 47 cells, n= 7102 displacements), and 2.0 µg per ml (N= 38 cells, n
= 3543 displacements) doxycycline. The cumulative distributions were fitted with three populations. Fitted parameters are shown in Supplementary
Table 9. b Normalized chromatin-bound populationðFN1 Þ. Unless otherwise indicated, the superscript N represents that a given value was normalized by the
Cbx7 level obtained from the immunostaining of Cbx7 (Fig. 7b) and by the chromatin-bound level at 0.1 µg per ml doxycycline. Results are means ± SD. c
Survival probability distribution of the dwell times for HaloTag-Cbx7 in SF8628 cells administrated with 0.1 µg per ml doxycycline replicated from Fig. 5, 1.0
µg per ml (N= 49 cells, n= 725 trajectories), and 2.0 µg per ml (N= 64 cells, n= 907 trajectories) doxycycline. The distributions were fitted with a two-
component exponential decay model. Fitted parameters are shown in Supplementary Table 10. d–f Normalized long-lived fraction (FN1sb) (d), residence time
(e), and search time (f) of the long-lived HaloTag-Cbx7 population. Results are means ± SD from three biological replicates. g A proposed mechanism that
underpins how increasing Cbx7 levels influences the binding and target search mechanism. Our data indicate that increasing Cbx7 levels has no effect on
the number of Cbx7 molecules on the specific sites, however, increases its level bound to the non-specific sites. The residence time of Cbx7 molecules on
the specific sites increases upon increasing Cbx7 levels. Increasing Cbx7 levels increases its search time, which is primarily due to the fact that Cbx7 takes
more trials of the non-specific chromatin collisions to reach a specific site. The thicker arrowhead represents a longer search time and the bigger font
depicts a prolonged residence time
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The minimal components required for the reconstitution of an
active PRC2 complex include Ezh2, Eed, and Suz1240,47,48. Our
analysis demonstrates that the depletion of Eed results in a ∼30%
reduction in both residence time and search time for Ezh2.
Consistently, we find that Eed has no effect on the long-lived
fraction of Ezh2. Previously, Suz12 was shown to be essential for
PRC2 binding to nucleosome48. Our analysis shows that the long-
lived fraction of Ezh2ΔSANT2 is ∼2.5-fold less than Ezh2. In
contrast to the Eed knockout, the deletion of SANT2 domain not
only prolongs the search process of Ezh2, but also reduces its
residence time. Studies have shown that Eed and Suz12 are
essential for the methyltransferase activity in vivo and
in vitro40,47,48. Our observations suggest that the number of Ezh2
molecules on chromatin and its target search time may not be a
good predictor for the PRC2 activity in vivo, since Eed knockout
has no effect on the long-lived fraction of Ezh2, and Suz12 and
Eed have opposite effects on the target search process of Ezh2.
We propose that the residence time of Ezh2 on chromatin may be
a better prediction for the methyltransferase activity of PRC2,
which is consistent with a recent report in which a prolonged
residence time increases the methyltransferase activity of PRC249.
The lengthened residence time gives sufficient time to reorient the
enzyme on chromatin, which produces a configuration that favors
the catalysis.
Studies have shown that H3K27M-nucleosomes are remark-
ably potent inhibitors of PRC2 and H3K27M peptides bind to the
PRC2 active site with above 20-fold higher affinity than the
equivalent peptides20,24,25. However, a recent study using
nucleosomes as substrates showed that the H3K27M mutation
has minor effects on PRC2-nucleosome binding27. The dis-
crepancy could be due to the experimental conditions, such as the
different substrates used (peptides vs. nucleosomes), the com-
position of PRC2 complexes, and the presence or absence of S-
adenosyl methionine. How do our single-molecule results
reconcile with the seemingly controversial results? In the binding
experiments27, the binding affinity was characterized by the dis-
sociation constant (KD), a ratio of off-rate vs. on-rate. Our in vivo
and in vitro single-molecule analysis demonstrates that the
H3K27M oncogenic mutation prolongs the residence time of
Ezh2 on H3K27M-nucleosome. The lengthened residence time
results in a reduction in the effective concentration of PRC2 by
sequestrating PRC2 on H3K27M-nucleosome, which leads to a
reduced reaction rate of trimethylation of H3K27 by PRC2
in vitro.
Our data show that increasing expression of Cbx7 inhibits the
proliferation of DIPG cells. A recent study demonstrated that
overexpression of Cbx7 arrests glioma cells in the G0/G1 phase15.
It has been well known that the activities of many nuclear factors
are regulated by modulating their concentration in the nucleus.
Our single-molecule analysis demonstrates that increasing Cbx7
protein levels has no effect on the number of long-lived Cbx7
molecules on the specific sites, but instead prolongs its residence
time. We propose that the prolonged residence time facilitates
recruiting other co-repressors by Cbx7, thereby repressing gene
transcription. Consistently, emerging evidence suggests that the
residence time of transcription factors directly correlates with
transcriptional output36,49–52. Further experiments are needed to
understand the causal relationship between residence time and
transcriptional activity.
In summary, our analysis immediately suggests that the resi-
dence time/stability directly correlates with the functions of PcG
proteins and highlights that the target search time plays a critical
role in regulating the genomic occupancy of PcG proteins. Per-
turbing the dynamic equilibrium of the overall system potentially
alters cellular physiologies.
Methods
Cell culture. The Ezh2−/− mES cells (Strain 129)7 were obtained from Dr. Stuart
Orkin (Harvard Medical School, Boston, MA). The PGK12.1 mES cells (a het-
erozygous for Strain PGK and Strain 129)53 were obtained from Dr. Neil Brock-
dorff (University of Oxford, UK). The Eed−/− mES cells (Strain 129)54 were
obtained from Dr. Haruhiko Koseki (RIKEN Center for Integrative Medical Sci-
ences, Japan). The patient-derived primary DIPG cells (SF8628) and the control
neural stem cells (9427)22 were obtained from Dr. Zhiguo Zhang (Columbia
University, Irving Cancer Research Center, New York). The HEK293T cells were
obtained from Dr. Tom K Kerppola (University of Michigan Medical School, Ann
Arbor, Michigan). All cell lines were tested negative for mycoplasma contamina-
tion by using DAPI DNA staining. SF8628 and 9427 cells were maintained in
DMEM medium (D5796; Sigma-Aldrich) supplemented with 10% FBS (97068-085;
VWR), 2 mM glutamine (25030–081; Life Technologies), 100 units per ml
penicillin-streptomycin (15140–122; Life Technologies) at 37 °C in 5% CO2. The
mES cells were maintained in DMEM (D5796; Sigma-Aldrich) supplemented with
15% FBS (97068-085; VWR), 2 mM glutamine (G7513; Life Technologies), 100
units per ml penicillin-streptomycin (15140-122; Life Technologies), 55 μM β-
mercaptoethanol (21985-023; Life Technologies), 103 units per ml leukemia inhi-
bitor factor, and 0.1 mM non-essential amino acids (11140050; Life Technologies)
at 37 °C in 5% CO2. The HEK293T cells were maintained in DMEM (D5796;
Sigma) supplemented with 10% FBS (97068-085; VWR), 2 mM glutamine (G7513;
Life Technologies), and 100 units per ml penicillin-streptomycin (15140-122; Life
Technologies) at 37 °C in 5% CO2.
Plasmids. The plasmids pTRIPZ (M1)-H2A-HT, pTRIPZ (M1)-HT-NLS, and
pTRIPZ (M1)-HT-Cbx7 have been deposited at Addgene (https://www.addgene.
org/Xiaojun_Ren/)28. Note that we have re-named pTRIPZ (M) as pTRIPZ (M1) in
this study. We replaced the puromycin-resistant gene in pTRIPZ (M1) with the
G418-resistant gene, generating pTRIPZ (M2). We amplified the HT-Ezh2, HT-
Eed, and HT-Cbx7 sequences and inserted them into pTRIPZ (M2) vector,
respectively, generating pTRIPZ (M2)-HT-Ezh2, pTRIPZ (M2)-HT-Eed, and
pTRIPZ (M2)-HT-Cbx7. We replaced the TRE-tight promoter in pTRIPZ (M1)-
HT-Cbx7 with the CMV promoter amplified from the plasmid pcDNA3.3 (+),
generating pTRIPZ (M1)-HT-Cbx7 (ΔTRE). We amplified the H3.3-FLAG-HA and
H3.3K27M-FLAG-HA sequences from pQCXIP-H3.3-FLAG-HA and pQCXIP-
H3.3K27M-FLAG-HA22 and used them to replace HT-Cbx7 in pTRIPZ (M1)-HT-
Cbx7 (ΔTRE), generating pTRIPZ (M1)-H3.3-FLAG-HA (ΔTRE) and pTRIPZ
(M1)-H3.3K27M-FLAG-HA (ΔTRE). We amplified the FLAG-HaloTag-Ezh2
sequence and inserted it to pTRIPZ (M1), generating pTRIPZ (M)-FLAG-HT-
Ezh2. To generate Ezh2 variants fused with HaloTag, the Ezh2 sequence in the
plasmid pTRIPZ (M1)-HT-Ezh2 was replaced with the Ezh2 variant sequences.
The Ezh2 variants were as follows: 1) Ezh2ΔSANT2, deletion of the SANT2 domain
(amino acid 318–478), and 2) Ezh2Catalytic, amino acid sequence 485–747. The
sequences encoding the fusion genes have been verified by DNA sequencing and
the plasmids are available at Addgene (https://www.addgene.org/Xiaojun_Ren/).
Establishing cell lines. Establishing the cell lines by lentivirus transduction was
carried out by using the published procedure28,55,56. HEK293T cells at 85–90%
confluency were co-transfected with 21 μg pTRIPZ (M) containing the fusion gene,
21 μg psPAX2, and 10.5 μg pMD2.G by using calcium phosphate precipitation. At
the time of 12 h after transfection, the medium was replaced with 10 ml DMEM
supplemented with 10% FBS, 2 mM L-glutamine, and 100 units per ml penicillin G
sodium. At the time of 50 h after medium change, the medium was harvested to
transduce cells in the presence of 8.0 µg per ml polybrene (H9268; Sigma-Aldrich,
St Louis, MO). For co-transducing multiple genes, lentiviruses were produced
separately and mixed at the time of transduction. At the time of 72 h after trans-
duction, infected cells were selected by using 1.0–2.0 μg per ml of puromycin
(P8833; Sigma-Aldrich, St Louis, MO) and/or 600–800 μg per ml G418 disulfate
salt (A1720, Sigma-Aldrich, St Louis, MO). Unless otherwise indicated, for live-cell
single-molecule imaging experiments, the fusions were expressed at the basal level
without administrating doxycycline.
Immunofluorescence. Wild-type (PGK12.1), Eed─/─, Ezh2─/─, HaloTag-Eed/
Eed─/─, and HaloTag-Ezh2/Ezh2─/─ mES cells and SF8628, 9427, HaloTag-Cbx7/
SF8628, and HaloTag-Cbx7/9427 cells were fixed using 2.0% paraformaldehyde.
After permeabilizing with 0.2% Triton X-100, we washed the cells with basic
blocking buffer (10 mM PBS pH 7.2, 0.1% Triton X-100, and 0.05% Tween 20) and
then with blocking buffer (the basic blocking buffer plus 3% goat serum and 3%
bovine serum albumin) overnight. Anti-H3K27me3 antibody (9733; Cell Signaling
Technology; 1:200 dilutions) or anti-Cbx7 antibody (ab21873; Abcam; 1:250
dilutions) was incubated with the cells for 2 h at room temperature. After washing
with the basic blocking buffer, we incubated cells with Alexa Fluor® 488-labeled
goat anti–rabbit antibody (A-11008; Life Technologies; 1:1000 dilutions) for 1 h.
After incubating with 25 ng per ml hoechst, we washed and mounted the cells on
slides with ProLong Antifade reagents (P7481; Life Technologies).
Growth curve. SF8628, 9427, HaloTag-Cbx7/SF8628, and HaloTag-Cbx7/9427
were seeded evenly into 6-well plates with the density at ∼7 × 104 cells per ml and
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administrated with a series of doxycycline concentration (0, 0.1, 0.2, 0.5, 1, and 2 µg
per ml). We incubated the cells at 37 °C in 5% CO2 for 7 days. The cells were
imaged and then counted using hemocytometer. The experiments were repeated
three times.
Live-cell SMT. Labeling HaloTag fusion protein with JF549in live cells: Labeling
HaloTag fusion protein with JF549 in living cells was performed using the previous
procedure28. Cells stably expressing HaloTag fusion protein were seeded to
gelation-coated cover-glass dish made in the laboratory. Following 24 h culture,
cells were treated using several concentrations (a range of 30–100 pM) of JF549 to
achieve 5–20 labeled molecules per frame. After 15-min incubation at 37 °C in 5%
CO2, cells were washed with cell culture medium and incubated in the cell culture
medium for 30 min at 37 °C in 5% CO2. The medium was replaced with the live-
cell imaging medium (A1896701, FluoroBrite DMEM, Life Technologies). Cells
were maintained at 37 °C using a heater controller (TC-324; Warner Instrument)
during imaging. Each dish was imaged for <1.5 h.
Single-molecule optical setup and image acquisition: The optical setup for live-
cell SMT is as follows. A Zeiss Axio Observer D1 Manual Microscopy (Zeiss,
Germany) equipped with an Alpha Plan-Apochromatic ×100/1.46 NA Oil-
immersion Objective (Zeiss, Germany) and an Evolve 512 × 512 EMCCD camera
with pixel size 16 µm (Photometrics, Tucson, AZ) was used for single-molecule
tracking. The overall magnification was ×250 through additional ×2.5
magnification on the emission pathway. The HILO illumination mode was used to
avoid stray-light reflection and reduce background from cell auto-fluorescence30.
For the excitation and emission of JF549, a Brightline® single-band laser filter set
(Semrock; excitation filter: FF01-561/14, emission filter: FF01-609/54, and dichroic
mirror: Di02-R561-25) was used. The microscope and the EMCCD camera were
controlled by Slidebook 6.0 software. Laser power intensity of ~10.6 mW per cm2
and ~3.4 mW per cm2 were used to study diffusion components and residence
times, respectively.
Single-molecule localization and tracking: We used U-track algorithm for
tracking and linking single particles57. U-track parameters used in this study are
listed in Supplementary Table 11. Prior to analysis, we visually checked stacks of
images. About one-third of stacks were discarded due to movement and drift. A
Matlab script was developed to process the output of 2D tracking from the u-track.
Extraction of bound fractions and diffusion constants: We extracted kinetic
fractions and diffusion constants of PcG proteins using Spot-On31, which was
developed by Hansen et al.31,46 based on a kinetic modeling framework described
by Mazza33. Briefly, for a Brownian motion in two dimensions, the probability that
a molecule starting at the origin will be at position r at time Δτ is given as follows
(Eq. 2).







The displacement histograms were fitted with the 3-state model (Eq. 3) by using
Matlab.













where σ is the single-molecule localization error. We denoted the F1 component as
the chromatin-bound population, F2 as the confined diffusion population, and F3
as the free diffusion population. Please note that F2 can also be molecules that non-
specifically associate with chromatin. The sum of F1, F2 and F3 equals 1.0. ZCORR is
a correct factor for de-focalization bias that considers the probability of molecules
moving out of the axial detection range, ΔZ, during delay time Δτ= 30 ms (Eqs. 4
and 5).
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where the coefficients (a, b) are from Monte Carlo simulations for a given diffusion
constant and are implemented in Spot-On31. The parameters used in the fitting are
listed in Supplementary Table 12.
In the above analysis, we assumed that the HaloTag-labeled molecules diffuse
isotopically along the three-dimensional axes X, Y, and Z. Thus, the XY projection
data reflect the 3D diffusion of the molecules. Live-cell SMT intends overestimating
the chromatin-bound molecules against freely diffusing molecules for two major
reasons. One bias is that 3D freely diffusing molecules will jump out of the Z axial
detection window58, which has been corrected by the Spot-On31. Another bias is
that 3D freely diffusing molecules tend to “motion blur” because they can move
several pixels during a short exposure time. The extent of the bias by motion blur is
sensitive to the experimental conditions and the localization algorithm31. To test
whether motion blur influences our conclusions, we performed a series of
experiments in which we fixed the lag time (30 ms), but varied the exposure times
(5, 10, 20 , and 30 ms) (Supplementary Figs. 4, 5). Motion blur caused a slight
overestimation of bound PcG proteins (Supplementary Table 5), but did not affect
our conclusions. It should be noted that even at <5 ms exposure time, motion blur
still contributes to the overestimation of bound PcG proteins. However, our optic
setup limits us to further reduce the exposure time due to signal-to-noise. Finally,
we assumed that the state transition between a bound molecule and an unbound
molecule with the lag time (30 ms) is negligible. Under our analysis, if we consider
the residence time as τtb= 1.0 s, the probability that a bound PcG unbinds during
30 ms is <3%, which was calculated as follows (Eq. 6).




Determination of residence time: To determine residence time, we performed
30-ms integration time and 170-ms dark time. Molecules with Dm ≤ 0.032 µm2 per
s were considered as chromatin-bound ones. We counted the dwell time of
individual molecules as their track length. We estimated the residence time using
the cumulative frequency distribution of dwell times as described in28,33,34,59. The
cumulative frequency distributions of dwell times were normalized for
photobleaching as described in28,33,34,59. The normalized cumulative frequency
distributions were fitted with a one- or two-component exponential decay function
(Eq. 7) based the F-test implemented in OriginLab.
y ¼ 1 f 1sb
 
eτ=τtb þ f 1sbeτ=τsb ð7Þ
where f1sb is the long-lived fraction of PcG on chromatin, and τtb and τsb are the
residence time of the short-lived and long-lived components, respectively. In the
following, we will use “tb” and “sb” as abbreviations for the short-lived and long-
lived population, respectively. Among the total PcG molecules within cells, the
fraction of the short-lived component (F1tb) and the long-lived component (F1sb)
were calculated as follows (Eqs. 8 and 9).
F1tb ¼ F1 ´ 1 f 1sb
  ð8Þ
F1sb ¼ F1 ´ f 1sb ð9Þ
where F1 is the bound fraction obtained from fitting the displacement distributions.
Determination of search dynamics: We estimated the nuclear search kinetics
developed by Loffreda et al.36 We assumed that PcG molecules generally exist in
either a bound or a freely diffusing state. We considered a two binding state model
(transient vs. stable binding). We assumed that binding to chromatin and
unbinding from chromatin are both first-order processes with rate constants ktb

on
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where F, N, and S represents the concentration of free, short-lived, and long-lived
molecules, respectively. By considering no dissociation, the probability f1sb was
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The target search time for finding a specific site was calculated as follows
(Eq. 11).
τsearch ¼ N trial ´ τ3D þ N trial  1ð Þτtb ð11Þ
where N trial is the average number of trials which one molecule needs to encounter
a specific site, N trial ¼ 1f 1sb. Please note that the number of trials should be
considered as minimum since very brief contacts with chromatin by PcG proteins
may not be able to be detected. τ3D is the average free time between two binding
events τ3D ¼ 1ksbon þktbon
 
.
By considering the system at equilibrium, the long-lived fraction (F1sb) was
related to the search time and the residence time.
F ´ ktbon  F ´ ksbon þ N ´ ktboff þ S ´ ksboff ¼ 0
F ´ ktbon  N ´ ktboff ¼ 0
F ´ ksbon  S ´ ksboff ¼ 0
The relationship among the long-lived fraction (F1sb), the residence time and the
search time was derived as follows (Eq. 12).




































¼ τsbN trial ´ τ3Dþ N trial1ð Þ ´ τtbþτsb
¼ τsbτsearchþτsb
ð12Þ
Thus, the long-lived fraction is determined by the residence time and the search
time. If two proteins have the same long-lived fraction, their residence time and
search time may be different. In contrast, if the two proteins have different long-
lived fractions, their residence time and search time may be the same.
In vitro single-molecule binding assay. Preparation of mononucleosome: The
K27M mutation in histone H3.3 (human) was introduced by PCR mutagenesis and
confirmed by sequencing. Expression and purification of recombinant human
histones, and subsequent assembly and purification of histone octamers, followed
established procedures60. A 216 bp DNA fragment containing the 601 nucleosome
positioning sequence was amplified by PCR using pGEM-3z/601 plasmid as the
template. The primers used were purchased from IDT (Coralville, IA):
/5Alexa488N/ACAGGATGTATATATCTGACACGTGCCTGG and /5Biosg/
TGACCAAGGAAAGCATGATTCTTCACAC. Purified PCR product was used to
assemble mononucleosomes by salt dilution61 and the quality of the nucleosomes
were confirmed by native PAGE.
Preparation of JF646-labeled Ezh2-PRC2 extract: FLAG-HaloTag-Ezh2/Ezh2−/−
mES cells were grown on two 15 cm gelatin-coated dishes in the presence of 1.0 µg
per ml doxycycline. When the confluency reached 95%, cells were collected,
resuspended in 2.0 ml of mES cell medium containing 50 nM of HaloTag ligand
Janelia Fluor 646 (JF646), and incubated at 37 °C in 5% CO2 for 30 min. After
centrifugation, cells were washed with 2× pre-chilled PBS buffer. To prepare nuclei,
cells were incubated in hypotonic buffer (10 mM HEPES pH 7.9, 1.5 mM MgCl2,
10 mM KCl, and 0.1 mM PMSF) for 10 min on ice, and dounced by glass
homogenizer for 12 times. Nuclei were collected at 1000 × g for 3 min at 4 °C and
incubated with 500 µl of pre-chilled nuclear lysis buffer containing (20 mM Tris-
HCl pH 7.4, 0.05% NP-40, 350 mM NaCl, 0.25 mM EDTA, 20% glycerol, 0.1 mM
Na3VO4, and protease inhibitor cocktail (P8340; Sigma-Aldrich) for 30 min. Lysate
were collected by centrifugation at 20,000×g for 20 min at 4 °C. To enrich JF646-
labeled Ezh2-PRC2, we performed one-step enrichment under mild conditions. 75
µl of pre-washed anti-Flag-M2 affinity gel (A2220; Sigma-Aldrich) were incubated
with nuclear lysate for 2 h at 4 °C. Protein–bead complexes were washed three
times with washing buffer (25 mM Tris-HCl, pH 7.4, 50 mM KCl, 5 mM MgCl2, 1
mM EDTA, 0.5 % NP-40, and 0.5 mg per ml BSA). JF646-labeled Ezh2-PRC2 was
eluted using elution buffer (washing buffer supplemented with 0.5 mg per ml of 3×
FLAG peptide).
Construction of flow cell: Flow cells were constructed according to the reported
procedure55. A coverslip (48366-249; VWR) was activated by aminosilane (N-2-
aminoethyl-3-aminopropyltrimethoxysilane (A21541; Pfaltz & Bauer) and then
functionalized with biotin PEG-SVA (256-586-9004; Laysan Bio, Arab, AL) and
mPEG-SVA (mPEG -SVA-5000; Laysan Bio). The coverslip was assembled to a
flow cell with a quartz slide (12-550-15; Thermo Fischer Scientific) having two 0.75
mm holes cross from each other using epoxy glue (14250; Devcon). The assembled
flow cell was stored at −20 °C under nitrogen gas.
Imaging by single-molecule microscopy: To each flow cell, 100 µl of solution
containing 0.1 mg per ml BSA and 0.2 mg per ml NeutrAvidin (31000; Thermo
Fisher Scientific) was loaded and incubated on ice for 15 min. The unbounded
NeutrAvidin was removed by flowing 100 µl of T50 buffer (10 mM Tris-HCl pH
8.0, 50 mM NaCl). Mononucleosome labeled with Biotin and Alexa Fluor 488 was
loaded into the flow cell and incubated on ice for 10 min. An aliquot of 10 µl of
JF646-labeled Ezh2-PRC2 extract was added to the flow cell. Images were acquired
by TIRF microscopy Zeiss Axio Observer D1 Manual Microscope (Zeiss, Germany)
equipped with an Alpha Plan-Apochromatic ×100/1.46 NA Oil Objective (Zeiss,
Germany) and an Evolve 512 × 512 EMCCD camera (Photometrics, Tucson, AZ).
The pixel size of the EMCCD was 16 µm. Additional ×2.5 magnification was used
to generate ×250 overall magnification. Alexa Fluor 488 and JF646 were excited at
488 nm and 640 nm, respectively, using a solid state laser stack (Intelligent Imaging
Innovations). A TIRF Laser Microscope Cube for 488/640 Excitation (C182369;
Chroma) was used to filter the excitation wavelength. A laser power intensity of
~10 mW per cm2 was used for exciting Alexa Fluor 488 and a power intensity of
~20 mW per cm2 for exciting JF646. The microscope and the EMCCD camera were
controlled by Slidebook 6.0 software. The position of nucleosome was recorded first
with a 200-ms exposure time, and then JF646 was track for 1000 frames with a 30-
ms integration time and 470-ms dark time. Finally, the position of nucleosome was
recorded again.
Data analysis: Data analysis was performed by using ImageJ (http://imagej.nih.
gov/ij/). We colocalized the positons of nucleosomes before and after imaging of
JF646-labeled Ezh2-PRC2 and discarded images where the positions do not
colocalize. About 80% of image stacks were discarded. We considered
JF646-labeled Ezh2-PRC2 molecules as binding to nucleosomes only if they
colocalize with nucleosome. The time traces of fluorescent intensity of JF646-labeled
Ezh2-PRC2 molecules were generated by ImageJ. The dwell time of individual
JF646-labeled Ezh2-PRC2 molecules were directly measured as the lifetime of the
fluorescence spots. The survival distribution of dwell time was necessary to fit with
one-component decay function based the F-test implemented in OriginLab.
y τð Þ ¼ Ae τ=τ0ð Þ ð13Þ
where τ0 is residence time and A is amplitude. Please note that the estimated
residence time is at the lower limitation since the photobleaching has not been
corrected.
Data availability. All relevant data are available from the authors on request.
https://figshare.com/articles/NCommunications-4-21-2018_xlsx/6169016
Received: 15 September 2017 Accepted: 26 April 2018
References
1. Li, B., Carey, M. & Workman, J. L. The role of chromatin during transcription.
Cell 128, 707–719 (2007).
2. Blackledge, N. P., Rose, N. R. & Klose, R. J. Targeting Polycomb systems to
regulate gene expression: modifications to a complex story. Nat. Rev. Mol. Cell
Biol. 16, 643–649 (2015).
3. Cao, R. et al. Role of histone H3 lysine 27 methylation in Polycomb-group
silencing. Science 298, 1039–1043 (2002).
4. Czermin, B. et al. Drosophila enhancer of Zeste/ESC complexes have a histone
H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell
111, 185–196 (2002).
5. Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P. & Reinberg,
D. Histone methyltransferase activity associated with a human multiprotein
complex containing the Enhancer of Zeste protein. Genes Dev. 16, 2893–2905
(2002).
6. Muller, J. et al. Histone methyltransferase activity of a Drosophila Polycomb
group repressor complex. Cell 111, 197–208 (2002).
7. Shen, X. et al. EZH1 mediates methylation on histone H3 lysine 27 and
complements EZH2 in maintaining stem cell identity and executing
pluripotency. Mol. Cell 32, 491–502 (2008).
8. Tavares, L. et al. RYBP-PRC1 complexes mediate H2A ubiquitylation at
polycomb target sites independently of PRC2 and H3K27me3. Cell 148,
664–678 (2012).
9. Gao, Z. et al. PCGF homologs, CBX proteins, and RYBP define functionally
distinct PRC1 family complexes. Mol. Cell 45, 344–356 (2012).
10. Laugesen, A. & Helin, K. Chromatin repressive complexes in stem cells,
development, and cancer. Cell Stem Cell 14, 735–751 (2014).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04455-7
14 NATURE COMMUNICATIONS |  (2018) 9:2080 | DOI: 10.1038/s41467-018-04455-7 | www.nature.com/naturecommunications
11. Pallante, P., Forzati, F., Federico, A., Arra, C. & Fusco, A. Polycomb protein
family member CBX7 plays a critical role in cancer progression. Am. J. Cancer
Res. 5, 1594–1601 (2015).
12. Comet, I., Riising, E. M., Leblanc, B. & Helin, K. Maintaining cell identity:
PRC2-mediated regulation of transcription and cancer. Nat. Rev. Cancer 16,
803–810 (2016).
13. Helin, K. & Dhanak, D. Chromatin proteins and modifications as drug targets.
Nature 502, 480–488 (2013).
14. Kim, K. H. & Roberts, C. W. Targeting EZH2 in cancer. Nat. Med. 22,
128–134 (2016).
15. Yu, T. et al. CBX7 is a glioma prognostic marker and induces G1/S arrest via
the silencing of CCNE1. Oncotarget 8, 26637–26647 (2017).
16. Lulla, R. R., Saratsis, A. M. & Hashizume, R. Mutations in chromatin
machinery and pediatric high-grade glioma. Sci. Adv. 2, e1501354 (2016).
17. Khuong-Quang, D. A. et al. K27M mutation in histone H3.3 defines clinically
and biologically distinct subgroups of pediatric diffuse intrinsic pontine
gliomas. Acta Neuropathol. 124, 439–447 (2012).
18. Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin
remodelling genes in paediatric glioblastoma. Nature 482, 226–231 (2012).
19. Wu, G. et al. Somatic histone H3 alterations in pediatric diffuse intrinsic
pontine gliomas and non-brainstem glioblastomas. Nat. Genet. 44, 251–253
(2012).
20. Lewis, P. W. et al. Inhibition of PRC2 activity by a gain-of-function H3
mutation found in pediatric glioblastoma. Science 340, 857–861 (2013).
21. Bender, S. et al. Reduced H3K27me3 and DNA hypomethylation are major
drivers of gene expression in K27M mutant pediatric high-grade gliomas.
Cancer Cell 24, 660–672 (2013).
22. Chan, K. M. et al. The histone H3.3K27M mutation in pediatric glioma
reprograms H3K27 methylation and gene expression. Genes Dev. 27, 985–990
(2013).
23. Mohammad, F. et al. EZH2 is a potential therapeutic target for H3K27M-
mutant pediatric gliomas. Nat. Med. 23, 483–492 (2017).
24. Justin, N. et al. Structural basis of oncogenic histone H3K27M
inhibition of human polycomb repressive complex 2. Nat. Commun. 7, 11316
(2016).
25. Brown, Z. Z. et al. Strategy for “detoxification” of a cancer-derived histone
mutant based on mapping its interaction with the methyltransferase PRC2. J.
Am. Chem. Soc. 136, 13498–13501 (2014).
26. Piunti, A. et al. Therapeutic targeting of polycomb and BET bromodomain
proteins in diffuse intrinsic pontine gliomas. Nat. Med. 23, 493–500
(2017).
27. Wang, X. et al. Molecular analysis of PRC2 recruitment to DNA in chromatin
and its inhibition by RNA. Nat. Struct. Mol. Biol. 24, 1028–1038 (2017).
28. Zhen, C. Y. et al. Live-cell single-molecule tracking reveals co-recognition of
H3K27me3 and DNA targets polycomb Cbx7-PRC1 to chromatin. Elife 5,
e17667 (2016).
29. Grimm, J. B. et al. A general method to improve fluorophores for live-cell and
single-molecule microscopy. Nat. Methods 12, 244–250 (2015).
30. Tokunaga, M., Imamoto, N. & Sakata-Sogawa, K. Highly inclined thin
illumination enables clear single-molecule imaging in cells. Nat. Methods 5,
159–161 (2008).
31. Hansen, A. S. et al. Robust model-based analysis of single-particle tracking
experiments with Spot-On. Elife 7, e33125 (2018).
32. Ren, X., Vincenz, C. & Kerppola, T. K. Changes in the distributions and
dynamics of polycomb repressive complexes during embryonic stem cell
differentiation. Mol. Cell Biol. 28, 2884–2895 (2008).
33. Mazza, D., Abernathy, A., Golob, N., Morisaki, T. & McNally, J. G. A
benchmark for chromatin binding measurements in live cells. Nucleic Acids
Res. 40, e119 (2012).
34. Morisaki, T., Muller, W. G., Golob, N., Mazza, D. & McNally, J. G. Single-
molecule analysis of transcription factor binding at transcription sites in live
cells. Nat. Commun. 5, 4456 (2014).
35. Swinstead, E. E. et al. Steroid receptors reprogram FoxA1 occupancy through
dynamic chromatin transitions. Cell 165, 593–605 (2016).
36. Loffreda, A. et al. Live-cell p53 single-molecule binding is modulated by C-
terminal acetylation and correlates with transcriptional activity. Nat.
Commun. 8, 313 (2017).
37. Paakinaho, V. et al. Single-molecule analysis of steroid receptor and cofactor
action in living cells. Nat. Commun. 8, 15896 (2017).
38. Chen, J. et al. Single-molecule dynamics of enhanceosome assembly in
embryonic stem cells. Cell 156, 1274–1285 (2014).
39. Gebhardt, J. C. et al. Single-molecule imaging of transcription factor binding
to DNA in live mammalian cells. Nat. Methods 10, 421–426 (2013).
40. Cao, R. & Zhang, Y. SUZ12 is required for both the histone methyltransferase
activity and the silencing function of the EED-EZH2 complex. Mol. Cell 15,
57–67 (2004).
41. Margueron, R. et al. Role of the polycomb protein EED in the propagation of
repressive histone marks. Nature 461, 762–767 (2009).
42. Xu, C. et al. Binding of different histone marks differentially regulates the
activity and specificity of polycomb repressive complex 2 (PRC2). Proc. Natl
Acad. Sci. USA 107, 19266–19271 (2010).
43. Pasini, D., Bracken, A. P., Jensen, M. R., Denchi, E. L. & Helin, K. Suz12 is
essential for mouse development and for EZH2 histone methyltransferase
activity. EMBO J. 23, 4061–4071 (2004).
44. Hetey, S. et al. Biophysical characterization of histone H3.3 K27M point
mutation. Biochem. Biophys. Res. Commun. 490, 868–875 (2017).
45. Jiao, L. & Liu, X. Structural basis of histone H3K27 trimethylation by an active
polycomb repressive complex 2. Science 350, aac4383 (2015).
46. Hansen, A. S., Pustova, I., Cattoglio, C., Tjian, R. & Darzacq, X. CTCF and
cohesin regulate chromatin loop stability with distinct dynamics. Elife 6,
e25776 (2017).
47. Montgomery, N. D. et al. The murine polycomb group protein Eed is required
for global histone H3 lysine-27 methylation. Curr. Biol. 15, 942–947 (2005).
48. Nekrasov, M., Wild, B. & Muller, J. Nucleosome binding and histone
methyltransferase activity of Drosophila PRC2. EMBO Rep. 6, 348–353
(2005).
49. Choi, J. et al. DNA binding by PHF1 prolongs PRC2 residence time on
chromatin and thereby promotes H3K27 methylation. Nat. Struct. Mol. Biol.
24, 1039–1047 (2017).
50. Stavreva, D. A., Muller, W. G., Hager, G. L., Smith, C. L. & McNally, J. G.
Rapid glucocorticoid receptor exchange at a promoter is coupled to
transcription and regulated by chaperones and proteasomes. Mol. Cell. Biol.
24, 2682–2697 (2004).
51. Lickwar, C. R., Mueller, F., Hanlon, S. E., McNally, J. G. & Lieb, J. D. Genome-
wide protein-DNA binding dynamics suggest a molecular clutch for
transcription factor function. Nature 484, 251–U141 (2012).
52. Clauss, K. et al. DNA residence time is a regulatory factor of transcription
repression. Nucleic Acids Res. 45, 11121–11130 (2017).
53. Penny, G. D., Kay, G. F., Sheardown, S. A., Rastan, S. & Brockdorff, N.
Requirement for Xist in X chromosome inactivation. Nature 379, 131–137
(1996).
54. Endoh, M. et al. Polycomb group proteins Ring1A/B are functionally linked to
the core transcriptional regulatory circuitry to maintain ES cell identity.
Development 135, 1513–1524 (2008).
55. Tatavosian, R. et al. Distinct cellular assembly stoichiometry of polycomb
complexes on chromatin revealed by single-molecule chromatin
immunoprecipitation imaging. J. Biol. Chem. 290, 28038–28054
(2015).
56. Zhen, C. Y., Duc, H. N., Kokotovic, M., Phiel, C. J. & Ren, X. Cbx2 stably
associates with mitotic chromosomes via a PRC2- or PRC1-independent
mechanism and is needed for recruiting PRC1 complex to mitotic
chromosomes. Mol. Biol. Cell 25, 3726–3739 (2014).
57. Jaqaman, K. et al. Robust single-particle tracking in live-cell time-lapse
sequences. Nat. Methods 5, 695–702 (2008).
58. Kues, T. & Kubitscheck, U. Single molecule motion perpendicular to the focal
plane of a microscope: application to splicing factor dynamics within the cell
nucleus. Single Mol. 3, 218–224 (2002).
59. Mazza, D., Ganguly, S. & McNally, J. G. Monitoring dynamic binding of
chromatin proteins in vivo by single-molecule tracking. Methods Mol. Biol.
1042, 117–137 (2013).
60. Dyer, P. N. et al. Reconstitution of nucleosome core particles from
recombinant histones and DNA. Methods Enzymol. 375, 23–44 (2004).
61. Owen-Hughes, T. et al. Analysis of nucleosome disruption by ATP-driven
chromatin remodeling complexes. Methods Mol. Biol. 119, 319–331 (1999).
Acknowledgements
We thank Dr. Haruhiko Koseki for providing Eed−/− mES cell lines, Drs. Stuart Orkin
and Xiaohua Shen for providing Ezh2−/− mES cell line, and Dr. Luke D. Lavis for
providing Janelia Fluor® Dyes. This work was supported, in whole or in part, by the
National Cancer Institute under Award Number R03CA191443 (to X.R.) and NIH
R01CA 204297 (to Z.Z.), the National Science Foundation under Award Number CHE-
1500285 (to H.W.), and the Office of Research Services (ORS) at University of Colorado
Denver.
Author contributions
R.T. established transgenic mESC lines, performed live-cell SMT, in vitro-binding assay,
immunofluorescence, and data analysis. T.N.H. constructed plasmids, established
transgenic mESC lines, performed the killing curve and immunofluorescence, and data
analysis. H.N.D. constructed plasmids, established mESC lines, and performed data
analysis. B.S. and Y.T. provided reconstituted nucleosomes. F.D. and Z.Z. provided cell
lines and plasmids. X.S. and Y.D. wrote Matlab script. C.P. provided analytic tools. H.W.
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04455-7 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:2080 | DOI: 10.1038/s41467-018-04455-7 | www.nature.com/naturecommunications 15
performed data analysis and supervised students. X.R. conceived and designed the study,
supervised and performed the experiments, analyzed data, prepared the figures, and
wrote the paper. All authors provide constructive comments for the manuscript.
Additional information
Supplementary Information accompanies this paper at https://doi.org/10.1038/s41467-
018-04455-7.
Competing interests: The authors declare no competing interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2018
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04455-7
16 NATURE COMMUNICATIONS |  (2018) 9:2080 | DOI: 10.1038/s41467-018-04455-7 | www.nature.com/naturecommunications
